title: Clinical validation of the cobas 4800 HPV test for cervical screening purposes.
abstract: This study shows that the clinical performance and reproducibility of the cobas 4800 HPV test for high-risk human papillomavirus (HPV) detection fulfill the criteria as formulated in international guidelines of HPV test requirements for cervical screening purposes. Accordingly, the cobas 4800 HPV test can be considered clinically validated for cervical screening.
authors: Department of Pathology, VU University Medical Center, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. dam.heideman@vumc.nl
authors: D A M
authors: DA
authors: Heideman
authors: A T
authors: AT
authors: Hesselink
authors: J
authors: J
authors: Berkhof
authors: F
authors: F
authors: van Kemenade
authors: W J G
authors: WJ
authors: Melchers
authors: N Fransen
authors: NF
authors: Daalmeijer
authors: M
authors: M
authors: Verkuijten
authors: C J L M
authors: CJ
authors: Meijer
authors: P J F
authors: PJ
authors: Snijders
mesh_terms: D000328:Adult; D055088:Early Detection of Cancer / Q000379:methods*; D005260:Female; D006801:Humans; D008875:Middle Aged; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D027383:Papillomaviridae / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000175:diagnosis* / Q000821:virology; D015203:Reproducibility of Results; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology